Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients

References

• Mills KR. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain 2003; 126: 2558–66
   PubMed Web of Science ®Google Scholar
• Toft MH, Gredal O, Pakkenberg B. The size distribution of neurons in the motor cortex in amyotrophic lateral sclerosis. J Anat 2005; 207: 399–407
   PubMed Web of Science ®Google Scholar
• Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RD. Natural history of amyotrophic lateral sclerosis. Neurology. 1993; 43: 1316–22
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C. Amyotrophic lateral sclerosis from bench to bedside. Semin Neurol 2008; 28: 205–11
   PubMed Web of Science ®Google Scholar
• Rowland LP, Schneider NA. Amyotrophic lateral sclerosis. Engl J Med. 2001; 344: 1688–700
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psych 2008; 79: 33–7
   PubMed Web of Science ®Google Scholar
• Cova L, Ratti A, Volta M, Foch I, Cardin V, Corbo M, Silani V. Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation. Stem Cells Dev 2004; 13: 121–31
   PubMed Web of Science ®Google Scholar
• Silani V, Cova L, Corbo M, Ciammola A, Polli E. Stem cell therapy for amyotrophic lateral sclerosis. Lancet 2004; 363: 200–2
   Google Scholar
• Issacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol 2003; 2: 417–23
   PubMed Web of Science ®Google Scholar
• Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Oliveri C, et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 158–61
   PubMed Web of Science ®Google Scholar
• Levy YS, Stroomza M, Melamed E, Offen D. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. J Mol Neurosc 2004; 24: 353–79
   PubMed Web of Science ®Google Scholar
• De Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, Clayton A, et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998; 16: 387–96
   PubMed Web of Science ®Google Scholar
• Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on SOD mice (amyotrophic lateral sclerosis). Life Sci 2000; 67: 53–9
   PubMed Web of Science ®Google Scholar
• Janson CG, Ramesh TM, During MJ, Leone P, Heywood J. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J Hematother Stem Cell Res 2001; 10: 913–15
   PubMedGoogle Scholar
• Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 2001; 115: 186–94
   PubMed Web of Science ®Google Scholar
• Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 12: 5002–12
   Google Scholar
• Matsumoto K, Kazuta Y, Yamashita N, Horie Y, Yamada T, Tani Y, et al. In vitro proliferation potential of AC133 positive cells in peripheral blood. Stem Cells 2000; 18: 196–203
   PubMed Web of Science ®Google Scholar
• Long X, Olszewski M, Huang W, Kletzel M. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Devel 2005; 14: 65–9
   PubMed Web of Science ®Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosc Reser 2000; 61: 364–70
   PubMed Web of Science ®Google Scholar
• Hung SC, Cheng H, Pan YP, Tsai MJ, Kao LS, Ma HL. In vitro differentiation of size-sieved stem cells into electrically active neural cells stem cells 2002; 20: 522–9
   Google Scholar
• Suon S, Jin H, Donaldson AE, Caterson EJ, Tuan RS, Deschennes G, et al. Transient differentiation of adult human bone marrow cells into neuron-like cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms. Stem Cell Devel 2004; 13: 625–35
   PubMed Web of Science ®Google Scholar
• Scintu F Reali C Pillai R Badiali M Sanna MA Argiolu F , et al. Differentiation of human bone marrow stem cells into cells with a neural phenotype: diverse effects of two specific treatments Neuroscience. 2006; doi: 10/1186/1417-2202,7–14.
   Web of Science ®Google Scholar
• Long X, Olszewski M, Huang W, Kletzel M. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Devel 2005; 14: 65–9
   PubMed Web of Science ®Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neuroscie Res 2000; 61: 364–70
   PubMed Web of Science ®Google Scholar
• Cho KJ, Trzaska T, Greco SJ, McArdle J, Wang FS, Ye JH, Rameshwara P. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1a. Stem Cells 2005; 23: 383–91
   PubMed Web of Science ®Google Scholar
• Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 190: 1779–82
   Google Scholar
• Borlongana CV, Evansa A, Yua G, Hessa DC. Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Res 2005; 1048: 116–22
   PubMed Web of Science ®Google Scholar
• Svendsen C, Langston JW. Stem cells for Parkinson's disease and ALS: replacement or protection?. Nature Med 2004; 10: 224–5
   PubMed Web of Science ®Google Scholar
• Swash M. Stem cell therapy in human ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 133–4
   PubMed Web of Science ®Google Scholar
• Moviglia GA, Fernandez Vina R, Brizuela JA, Saslavsky J, Vrsalovic F, Varela G, et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 2006; 8: 202–9
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zhang SZ, Xu RX, Xu K. Neuronal stem cell transplantation and postoperative management: report of 70 cases. Di Yi Jun Yi Da Xue Xue Bao 2004; 24: 1207–9
   PubMedGoogle Scholar
• Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med 2006; 29: 191–203
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis workshop contributors. J Neurol Sci 1994; 124(Suppl)96–107
   PubMed Web of Science ®Google Scholar
• Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research. J Neurol Sci 1999; 169: 2–12
   PubMed Web of Science ®Google Scholar
• John J. Grading of muscle power: comparison of MRC and analogous scales by physiotherapists. Int J Rehab Res 1984; 7: 173–81
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Levy G, Thompson JLP, DelBene ML. The ALSFRS-R predicts survival time in an ALS clinic population. Neurology 2005; 64: 39–43
   Web of Science ®Google Scholar
• Hashimoto H, Itoh M, Nishimura M, Asai T. Effect of filgrastim for steady-state mobilization of peripheral blood stem cells. Ther Apher 2002; 6: 431–6
   PubMedGoogle Scholar
• Kröger N, Renges H, Krüger W, Gutensohn K, Löliger C, Carrero I, et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 2000; 111: 761–5
   PubMed Web of Science ®Google Scholar
• Gordon PH, Moore DH, Tandan R, Florence JM, Verheijde JL, Doorish C, et al. for the Western ALS Study Group. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurol 2007; 6: 1045–53
   PubMed Web of Science ®Google Scholar
• Gordon PH, Moore DH, Miller RG, Gelinas DF, Qualls C, Meister ME, Werner J, et al. Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 2004; 62: 1845–7
   PubMed Web of Science ®Google Scholar
• Cheung YK, Gordon PH, Levin B. Selecting promising ALS therapies in clinical trials. Neurology 2006; 67: 1748–51
   PubMed Web of Science ®Google Scholar
• Couzin J. Clinical research: ALS trial raises questions about promising drug. Science. 2007; 318: 1227
   PubMed Web of Science ®Google Scholar